WASHINGTON, Aug. 10, 2015 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical
company focused on the development and commercialization of
products for the treatment of central nervous system disorders,
today announced that Jim Kelly,
Vanda's Senior Vice President and Chief Financial Officer, will
deliver a corporate presentation at the Canaccord Genuity Annual
Growth Conference in Boston,
Massachusetts on Wednesday, August
12, 2015 at 1:30 p.m. Eastern
Time.
The presentation at the Canaccord Genuity Annual Growth
Conference will be available live on Vanda's corporate website,
where it also will be archived for 30 days. To access the
presentation, go to Vanda's website at www.vandapharma.com and
click on the Presentations tab on the Investor Relations page.
Please connect to the website several minutes prior to the
start of the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company
focused on the development and commercialization of products for
the treatment of central nervous system disorders. For more on
Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.
Company Contact:
Jim
Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-present-at-the-canaccord-genuity-annual-growth-conference-300125816.html
SOURCE Vanda Pharmaceuticals Inc.